Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -243.10K | -278.50K | -279.20K | -592.60K | 3.23M |
| Total Depreciation and Amortization | 21.80K | 25.00K | 24.60K | 24.20K | 49.00K |
| Total Amortization of Deferred Charges | 21.90K | 27.20K | 30.20K | 63.30K | 132.90K |
| Total Other Non-Cash Items | 41.90K | 27.90K | 36.80K | 156.80K | -4.35M |
| Change in Net Operating Assets | -28.70K | 114.20K | 800.00 | 255.50K | 885.90K |
| Cash from Operations | -186.20K | -84.20K | -186.80K | -92.80K | -54.00K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 83.60K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 33.50K | -9.80K | 10.00K | 51.50K |
| Cash from Investing | 83.60K | 33.50K | -9.80K | 10.00K | 51.50K |
| Total Debt Issued | 198.70K | 230.20K | 276.90K | 203.20K | 304.70K |
| Total Debt Repaid | -96.10K | -179.50K | -80.20K | -120.40K | -302.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.60K | 50.70K | 196.70K | 82.80K | 2.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | 0.00 |